Invivyd, Inc. (IVVD)
NASDAQ·Healthcare·Biotechnology
$1.41
-3.77%
Mkt Cap $193.78M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | $17.20M | $17.20M | +0.00% | -$0.06 | $0.02 | +133.33% | — | — |
| Q4 2025 Nov 6, 2025 | $15.52M | $13.13M | -15.38% | -$0.05 | -$0.06 | -20.00% | — | — |
| Q3 2025 Aug 14, 2025 | $29.00M | $11.79M | -59.37% | -$0.04 | -$0.12 | -200.00% | — | — |
| Q2 2025 May 15, 2025 | $17.50M | $11.30M | -35.41% | -$0.04 | -$0.14 | -250.00% | — | — |
| Q1 2025 Mar 20, 2025 | $34.45M | $13.82M | -59.88% | -$0.25 | -$0.15 | +40.00% | — | — |
| Q4 2024 Nov 14, 2024 | $13.87M | $9.30M | -32.93% | -$0.33 | -$0.51 | -54.55% | — | — |
| Q3 2024 Aug 14, 2024 | $5.00M | $2.26M | -54.72% | -$0.37 | -$0.40 | -8.11% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.51 | -$0.38 | +25.49% | — | — |
| Q1 2024 Mar 28, 2024 | — | $3.02M | — | -$0.41 | -$0.67 | -63.41% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.54 | -$0.36 | +33.33% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.40 | -$0.46 | -15.00% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.36 | -$0.32 | +11.11% | — | — |
| Q1 2023 Mar 23, 2023 | — | — | — | -$0.39 | -$0.41 | -5.13% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$0.46 | -$0.42 | +8.70% | — | — |
| Q3 2022 Aug 15, 2022 | — | — | — | -$0.57 | -$0.47 | +17.54% | — | — |
| Q2 2022 May 13, 2022 | — | — | — | -$0.82 | -$0.93 | -13.41% | — | — |
| Q1 2022 Mar 30, 2022 | — | — | — | -$1.03 | -$0.77 | +25.24% | — | — |
| Q4 2021 Nov 15, 2021 | $2 | $3 | +50.00% | -$0.74 | -$0.98 | -32.43% | — | — |
| Q3 2021 Sep 20, 2021 | — | — | — | -$0.80 | -$0.18 | +77.50% | — | — |
| Q3 2021 Aug 6, 2021 | — | — | — | — | -$0.61 | — | — | — |